Venkataramana Kandi
Also known as: Venkataramana Kandi, Ramana K. V., Venkata Ramana Kandi
Prathima Institute of Medical Sciences, Universidad Central de Nicaragua, NTR University of Health Sciences, Kasturba Medical College
About
Dr. Venkataramana Kandi completed a Master's in Medical Microbiology from the Faculty of Medicine, Manipal University in India. He registered for a Ph.D. from Dr. NTR University of Health Sciences, India, and obtained Ph.D. by publication from ASU (America). He also obtained a Ph.D. in Clinical Research from the University of Central Nicaragua. He is elected to the National Academy of Medical Sciences (NAMS) (MAMS). He has been conferred with the Fellowship of the Royal College of Pathologists (FRCPath), London, UK (2024). He also holds life membership of the Indian Association of Medical Microbiologists (LM 1919) and the Association of Microbiologists of India (AMI) (AMI/LM-465/2013). He was accepted as a Member of the Asian Council for Science Editors (ACSE) (2015, 2021). He presented and published more than 305 scientific research papers in National and International conferences and journals with more than 5512 citations. (https://scholar.google.com/citations?user=cbBUvuQAAAAJ&hl=en).
My research interest includes wide areas of Medical Microbiology
Employment
-
Prathima Institute of Medical Sciences Teacher2010 - Present
Education
-
Universidad Central de Nicaragua Ph.D.2019 - 2021
-
NTR University of Health Sciences PhD2009 - 2013
-
Kasturba Medical College
Projects & Funding
Projects & funding information is unavailable.
Publications (293)
- Serratia marcescens as an Uncommon Cause of Infection Following Craniectomy: A Case Report and Literature Review Save
- The Need for an Ombudsman in the Indian Medical Education and Health System: A Medical Teacher’s Perspective Save
- Guillain-Barré Syndrome Outbreak in Pune, India, Calls for Heightened Awareness and Preparedness Save
- Are Medical Graduates Adequately Trained? A Critical Viewpoint on Factors Influencing Medical Education in India Save
- The advantages of working with a central laboratory for conducting clinical trials Save
- Artificial intelligence enhanced infectious disease surveillance - A call for global collaboration Save
- Deadly Sudan virus reemerges in Uganda after 10 years – a potential public health threat in the COVID-19 era: a situational analysis Save
- Need of Monkeypox animal vaccine and its global distribution: right time to address? Save
- The emergence of the circulating vaccine-derived poliovirus type 2 in multiple countries requires active surveillance: current scenario and counteracting strategies Save
- Did Previous Exposure to Bat Urine and Feces Influence the Disease Outcomes of COVID-19 Caused by the Novel SARS-CoV-2? Save